Antares Vision, a global provider of serialization-based track-and-trace products for the pharmaceutical industry, has introduced the Antares Vision Quick Compliance Program, which draws upon a large lineup of pre-configured modules to enable serialization compliance within 10 weeks from the project start.
Accessibility of infrastructure and speed to deployment have become paramount as U.S. regulatory deadlines loom. The next milestone for manufacturers to comply with 2013’s Drug Supply Chain Security Act is Nov. 27, 2017, by which date pharmaceutical manufacturers are required to print a unique product identification code on all Rx units of sale and homogenous cases distributed domestically.
The looming deadline makes the Antares Vision Quick Compliance Program particularly prescient, as Antares guarantees a fully integrated, validated, and complete serialization program in such a short timeframe. The program is based on preconfigured modules in concert with a standardized package of software, documentation and services, minimizing the need for Project Management Office (PMO) efforts. All units, which also offer post-implementation flexibility and scalability, are preconfigured in Antares Vision’s new Moorestown, NJ, warehouse space, and are ready-to-ship.
